Published 2018 | Version v1
Publication

CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Additional details

Identifiers

URL
http://hdl.handle.net/11567/914957
URN
urn:oai:iris.unige.it:11567/914957

Origin repository

Origin repository
UNIGE